![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 471/04 | (2006.01) |
A61K 31/437 | (2006.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 17/00 | (2006.01) | ||
A61P 27/02 | (2006.01) |
(11) | Number of the document | 3601283 |
(13) | Kind of document | T |
(96) | European patent application number | 18724754.9 |
Date of filing the European patent application | 2018-04-30 | |
(97) | Date of publication of the European application | 2020-02-05 |
(45) | Date of publication and mention of the grant of the patent | 2021-12-29 |
(46) | Date of publication of the claims translation | 2022-02-25 |
(86) | Number | PCT/US2018/030148 |
Date | 2018-04-30 |
(87) | Number | WO 2018/204238 |
Date | 2018-11-08 |
(30) | Number | Date | Country code |
201762492574 P | 2017-05-01 | US |
(72) |
FATHEREE, Paul R. , US
JIANG, Lan , US
MCKINNELL, Robert Murray , US
THALLADI, Venkat R. , US
ZHANG, Hao , US
DABROS, Marta , US
NZEREM, Jerry , US
BENJAMIN, Noah , US
KLEINSCHEK, Melanie A. , US
CRATER, Glenn D. , US
|
(73) |
Theravance Biopharma R&D IP, LLC ,
901 Gateway Boulevard, South San Francisco, CA 94080,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Kondensuoto imidazo-piperidino JAK inhibitoriaus junginys |
FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND |
Payment date | Validity (years) | Amount | |
2023-04-03 | 6 | 139.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2024-04-30 |